Evidence map›Paper›PMID 21670206›Full record

ArticleThe Journal of general physiology2011

Functional properties and toxin pharmacology of a dorsal root ganglion sodium channel viewed through its voltage sensors.

Frank Bosmans, Michelino Puopolo, Marie-France Martin-Eauclaire, Bruce P Bean, Kenton J Swartz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of general physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. A disease mutation reveals a role for NaV1.9 in acute itch.The Journal of clinical investigation · 2018
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Frank BosmansMolecular Physiology and Biophysics Section, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Frank.Bosmans@-nih.gov
Michelino Puopolo
Marie-France Martin-Eauclaire
Bruce P Bean
Kenton J Swartz
Harvard University · USInstitut de Neurobiologie de la Méditerranée · FRNational Institute of Neurological Disorders and Stroke · USNational Institutes of Health · US

Funding

Gating mechanisms and pharmacology of sodium and calcium channelsZIANS003017 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SWARTZ, KENTON · 2009 to 2014
$3.3M
Selective targeting of sodium channel blockers to pain-sensing neuronsR01NS064274 · NINDS · HARVARD MEDICAL SCHOOL · PI BEAN, BRUCE P · 2009 to 2012
$1.5M
Intramural NIH HHSNINDS NIH HHS R01 NS064274
6 · The paper itself

Abstract

The voltage-activated sodium (Nav) channel Nav1.9 is expressed in dorsal root ganglion (DRG) neurons where it is believed to play an important role in nociception. Progress in revealing the functional properties and pharmacological sensitivities of this non-canonical Nav channel has been slow because attempts to express this channel in a heterologous expression system have been unsuccessful. Here, we use a protein engineering approach to dissect the contributions of the four Nav1.9 voltage sensors to channel function and pharmacology. We define individual S3b-S4 paddle motifs within each voltage sensor, and show that they can sense changes in membrane voltage and drive voltage sensor activation when transplanted into voltage-activated potassium channels. We also find that the paddle motifs in Nav1.9 are targeted by animal toxins, and that these toxins alter Nav1.9-mediated currents in DRG neurons. Our results demonstrate that slowly activating and inactivating Nav1.9 channels have functional and pharmacological properties in common with canonical Nav channels, but also show distinctive pharmacological sensitivities that can potentially be exploited for developing novel treatments for pain.

Indexed as

AnimalsGanglia, SpinalHumansIon Channel GatingNeuronsOocytesRatsSodium ChannelsVenomsXenopusSodium ChannelsVenoms

Identifiers

PMID21670206
PMCPMC3135324
OpenAlexW2121044649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.